|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 227.26 USD | -0.67% |
|
-0.15% | -5.49% |
| 15/04 | Baird Adjusts Price Target on ResMed to $254 From $272, Maintains Neutral Rating | MT |
| 13/04 | Mizuho Adjusts Price Target on ResMed to $255 From $300, Maintains Outperform Rating | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 240.87 | 245.73 | 252.55 |
| Spread/Res. | -5.49% | -7.36% | -9.86% |
| Spread/Supp. | +3.46% | +3.46% | +3.25% |
| Support | 220.03 | 220.03 | 220.47 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- RMD Stock
- Charts ResMed, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















